Western Pacific Wealth Management, LP
Source: SEC Form 13F · as of Mar 2026Western Pacific Wealth Management, LP holds 19 biotech & pharma companies tracked by BioSniper, totaling $2.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$2.1M
| Company | Shares | Value |
|---|---|---|
| ICLRICON plc | 2,845 | $315K |
| IQVIQVIA Holdings Inc. | 1,713 | $292K |
| ELVElevance Health Inc. | 947 | $277K |
| GMOptec International, Inc. | 2,723 | $203K |
| ABBVAbbVie Inc. | 827 | $180K |
| ABTABBOTT LABORATORIES | 1,562 | $160K |
| CRSPCRISPR Therapeutics AG | 3,300 | $157K |
| AMGNAMGEN INC | 380 | $134K |
| IDXXIDEXX LABORATORIES INC /DE | 210 | $118K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 397 | $107K |
| LLYELI LILLY & Co | 50 | $46K |
| MRKMerck & Co., Inc. | 263 | $32K |
| CRVSCorvus Pharmaceuticals, Inc. | 2,000 | $29K |
| JNJJOHNSON & JOHNSON | 75 | $18K |
| DFTXDefinium Therapeutics Inc. | 333 | $6K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 1,000 | $3K |
| NVONovo Nordisk A/S | 80 | $3K |
| SNYSanofi | 50 | $2K |
| CMPSCOMPASS Pathways plc | 50 | $277 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.